最新的帖子

一月 21, 2021

West's Envision™ Verification System – Risk Mitigation for Quality of Drug Product

One factor of parenteral drug product quality is the container closure integrity (CCI) of the primary packaging system. The interaction between the sealing surface of the elastomeric component and the vial is vital to ensure stability of the drug product over the shelf life. Therefore, defects found on the elastomeric component can increase the risk of failure or end-of-the-line rejects.
Cathy Chhour

Cathy Chhour

Sr. Specialist, Regulatory Affairs

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • 以前的博客

    十二月 28, 2020

    Particles in Injectable Drugs

    Lynn Yao

    Lynn Yao

    Manager, Scientific Affairs, CN

    十二月 17, 2020

    Guideline for Nitrosamine Impurities in China

    Candice Sun

    Candice Sun

    Specialist, Scientific Affairs, CN

    Stoppers

    十一月 20, 2020

    New USP Chapters <381>, <382>, <1381>, and <1382>

    Daniel Bantz

    Daniel Bantz

    Manager, Scientific Communications, Self Injection Systems

    十一月 09, 2020

    New Method for Endotoxin Quantification

    Olga Laskina

    Olga Laskina PhD.

    Sr. Technical Account Specialist, TCS NA

    十一月 05, 2020

    PDA and West Sponsor Symposium on Combination Products

    Fran DeGrazio

    Fran DeGrazio

    Chief Scientific Officer, Scientific Affairs

    Load more